drugset / Trial / NCT01857011

Iron Supplementation for Acute Anemia After Postbariatric Abdominoplasty

NCT01857011

Phase 3 Completed 56 enrolled Federal University of São Paulo
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether intravenous or oral iron are effective in the treatment of postoperative anemia and iron deficiency in patients submitted in postbariatric abdominoplasty.

Timeline

Start
2014-04
Primary completion
2016-04
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iron III Hydroxide Polymaltose Complex Unknown 100 mg Oral
Subject Iron sucrose Unknown 200 mg Intravenous